You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 15, 2026

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
Published on: September 22, 2011
Sarah Zimmermann1, Sarah Gretzinger2, Marie-Luise Schwab3
1Karlsruhe Institute of Technology (KIT), Institute of Process Engineering in Life Science, Section IV: Biomolecular Separation Engineering (MAB), Engler-Bunte-Ring 3, 76131 Karlsruhe, Germany.
Automated screening of aqueous two-phase systems (ATPS) enables efficient cell separation for cell-based therapeutics. This high-throughput platform optimizes downstream processing, achieving high purity and recovery of specific cell populations.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: